It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Advanced Search
Toggle navigation
Commercial
Home
Commercial Policies
Currently selected
Medicare Advantage Policies
MA PPO Host Policies
Contact Us
Commercial
Medical Policy
Policy Bulletins
Active Policy Notifications
Policy Types and Descriptions
Services Requiring Precertification
Coverage Guidelines
Select Cardiology Guidelines
Diagnostic Radiology Guidelines
Lab Management Guidelines
Musculoskeletal Guidelines
Radiation Therapy Guidelines
Sleep Disorder Management Guidelines
Specialty Medical Benefit Drugs
News & Announcements
Site Activity
Currently selected
Contact Us
MPDocType
Title
MPPolicyNumber
MPNotificationIssuedDate
MPEffectiveDate
MPReissuedDate
MPArchiveNotifEffDate
MPSALogCreatedOn
MPPolicyChangeTypeslt
MPRevisionDate
MPSiteActivityRemovedDate
News & Announcements
Preventive Coverage Update of Human Papillomavirus (HPV) Screening for Commercial members (Retroactively effective 01/01/2025)
5/4/2026
Notifications
Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists, VEGF Biosimilars, and Combination VEGF/Angiopoietin-2 (Ang-2) Inhibitors
08.00.74ac
5/4/2026 3:00 PM
8/3/2026
5/4/2026
Medical Necessity Criteria
Updated Policies
Hospital Readmissions
00.01.47d
4/1/2026 2:00 PM
5/1/2026
5/1/2026
Coverage and/or Reimbursement Position;General Description, Guidelines, or Informational Update
Updated Policies
Talquetamab-tgvs (Talvey®)
08.02.16a
5/4/2026
5/4/2026
Medical Necessity Criteria;Medical Coding
Updated Policies
Teclistamab-cqyv (Tecvayli®)
08.01.98d
5/4/2026
5/4/2026
Medical Necessity Criteria;Medical Coding
Updated Policies
Elranatamab-bcmm (Elrexfio®)
08.02.18a
5/4/2026
5/4/2026
Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
Updated Policies
Retifanlimab-dlwr (Zynyz®)
08.02.05d
5/4/2026
5/4/2026
Medical Necessity Criteria
Updated Policies
Preventive Care Services
00.06.02ay
4/1/2026
5/5/2026
Medical Necessity Criteria;Medical Coding
5/5/2026
Updated Policies
Routine/Non-routine Vaccines
08.01.04ai
5/18/2026
5/18/2026
Medical Necessity Criteria;Medical Coding
Coding Update
Therapies for Spinal Muscular Atrophy Nusinersen (Spinraza®) and Onasemnogene abeparvovec-xioi (Zolgensma®)
08.01.36g
4/1/2026
5/6/2026
Coding Update
Repair or Replacement of an External Prosthetic Device
05.00.45l
4/1/2026
5/14/2026
Follow
javascript: SP.SOD.executeFunc('followingcommon.js', 'FollowDoc', function() { FollowDoc('{ListId}', {ItemId}); });
0x0
0x0
ContentType
0x01
1100
Compliance Details
javascript:if (typeof CalloutManager !== 'undefined' && Boolean(CalloutManager) && Boolean(CalloutManager.closeAll)) CalloutManager.closeAll(); commonShowModalDialog('{SiteUrl}'+ '/_layouts/15/itemexpiration.aspx' +'?ID={ItemId}&List={ListId}', 'center:1;dialogHeight:500px;dialogWidth:500px;resizable:yes;status:no;location:no;menubar:no;help:no', function GotoPageAfterClose(pageid){if(pageid == 'hold') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/hold.aspx' +'?ID={ItemId}&List={ListId}'); return false;} if(pageid == 'audit') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/Reporting.aspx' +'?Category=Auditing&backtype=item&ID={ItemId}&List={ListId}'); return false;} if(pageid == 'config') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/expirationconfig.aspx' +'?ID={ItemId}&List={ListId}'); return false;}}, null);
0x0
0x1
ContentType
0x01
898
Document Set Version History
/_layouts/15/images/versions.gif?rev=40
javascript:SP.UI.ModalDialog.ShowPopupDialog('{SiteUrl}'+ '/_layouts/15/DocSetVersions.aspx' + '?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
330
Send To other location
/_layouts/15/images/sendOtherLoc.gif?rev=40
javascript:GoToPage('{SiteUrl}' + '/_layouts/15/docsetsend.aspx' + '?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
350
Decline
Accept and go to Medical Policies
|
Decline